Allogene (ALLO) news
Recent news
Payward-Saldo deal seen closing in 2027
The anticipated merger between Payward and Saldo, two prominent players in the digital payments sector, is expected to finalize in 2027, according to recent regulatory filings and internal communications from both companies. The deal, which has been under review by antitrust authorities since early…
AInvest Wire · 1d agoTPG no longer holds Allogene common stock
AInvest Wire · Sep 30, 2026TPG sold 18.7M Allogene shares at $1.55 each on Sept. 28
AInvest Wire · Sep 30, 2026Allogene announces retirement of CFO Geoffrey Parker
AInvest Wire · Sep 2, 2026Allogene Therapeutics files $500M mixed securities shelf
Allogene Therapeutics, Inc. (Nasdaq: ALLO) has filed a mixed securities shelf registration with the Securities and Exchange Commission (SEC), allowing the company to offer and sell up to $500 million in securities over time, subject to market conditions and investor demand. This filing expands the…
AInvest Wire · Aug 12, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.